Pain Management

Resources

Basic InformationMore InformationLatest News

Sucrose May Not Be Effective Analgesic in NewbornsQuality of Pain Counts as Much as Intensity, Researchers SayMany With Chronic Pain Get Inadequate Relief, Study FindsSingle Genetic Factor Related to Pain at Many Body SitesWomen Experience More Chronic Pain Than Men, Research FindsHealth Tip: Help Tame Chronic PainChronic Pain Often Follows U.S. Soldiers Home: StudyHealth Tip: Things That Can Aggravate Arthritis PainDepression Can Make Pain WorseCommon Pain Relievers Raise Heart Risk for Healthy FolksBrain Scans Show How Meditation Calms PainAcupuncture May Trigger Natural PainkillerNew Tramadol Label Warns of Suicide, Overdose RisksSprix Approved for Moderate-to-Severe PainGenetic Research Sheds Light on Chronic PainEducation Program in Primary Care Can Help Low Back PainDevice Provides Sustained Pain Relief for Migraines With AuraStudy Examines Low Back Pain Therapy TechniquesOxygen Useful in Treating Cluster Headache PainBrazilian Mint Tea Naturally Good for Pain ReliefChronic Pain Trips Up SeniorsLow-Level Laser Treatment May Help Ease Neck PainBad Mood May Make Pain WorseChronic Pain Can Be a Problem Years After Breast SurgeryPost-Surgical Pain in Children Can Be Effectively ManagedPain Among Men and Women War Veterans EvaluatedSome People Vulnerable to Persistent Post-Op PainCorticosteroid Shot Helpful in Post-Pregnancy Back PainHealth Tip: Manage Pain Without DrugsMany Chronic Low Back Pain Patients Recover Within a YearPain Robs Years From Folks at Mid-LifePrevalence of Alcohol as Self-Medication for Pain AssessedCombination Treatment Found Effective for Neuropathic PainDrug Combo May Offer Best Relief for Nerve Pain

Questions and AnswersLinks

Related Topics

Depression: Major Depression & Unipolar Varieties
Medical Disorders
Mental Disorders

Sprix Approved for Moderate-to-Severe Pain

by -- Scott Roberts
Updated: May 17th 2010

MONDAY, May 17 (HealthDay News) -- Roxro Pharma's Sprix (ketorolac tromethamine) nasal spray has been approved by the U.S. Food and Drug Administration for the short-term treatment of moderate to moderately severe pain, the manufacturer said Monday in a news release.

The nasal spray contains the non-steroidal anti-inflammatory drug (NSAID) ketorolac. The non-narcotic medication minimizes the chances for abuse and eliminates side effects associated with narcotic pain relievers, the drug maker said.

The drug should not be used for longer than five days. Potential side effects may include peptic ulcers or gastrointestinal bleeding, and the drug shouldn't be used in people who already have these conditions, a high risk of bleeding, or advanced renal failure, the company said.

Roxro is based in Menlo Park, Calif.

More information

The U.S. National Library of Medicine has more about pain relievers.

This article: Copyright © 2010 HealthDay. All rights reserved.

GULF BEND CENTER
6502 Nursery Drive, Suite 100
Victoria, Texas 77904

Hours
Monday - Friday
8 am - 5 pm

24-Hour Crisis Hotline
1 (877) 723-3422
1 (877) SAFEGBC

Phone
(361) 575-0611

Toll Free Administration Line
1 (800) 421-8825

Fax
(361) 578-0506

Enterprise Survey Software Powered by

Career Map

American Association of Suicidology